Development of a Novel Chemoenzymatic Process for ( S )-1-(Pyridin-4-yl)-1,3-propanediol

Hong-Yi Wang,Jia-Wei Tang,Peng Peng,Hai-Jun Yan,Fu-Li Zhang,Shao-Xin Chen
DOI: https://doi.org/10.1021/acs.oprd.0c00403
2020-11-25
Abstract:We first developed a novel and efficient chemoenzymatic process to prepare (<i>S</i>)-1-(pyridin-4-yl)-1,3-propanediol, a vital HepDirect prodrug intermediate, from inexpensive and commercially available isonicotinic acid. Through this process, we provide a creative way to obtain the key chiral intermediate, β-hydroxyester, with ketoreductase (KRED) EA. After optimization of the process, we performed the reaction on a 100 g scale with a substrate concentration of up to 150 g/L, a yield of 93%, and an ee value of up to 99.9%. Additionally, we used a simple and effective NaBH<sub>4</sub>/MgCl<sub>2</sub> reduction system to obtain (<i>S</i>)-1-(pyridin-4-yl)-1,3-propanediol with &gt;99.9% ee and an 80% yield. This novel chemoenzymatic process has the potential to be a cost-effective and environmentally friendly process suitable for industrial use.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.oprd.0c00403?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.oprd.0c00403</a>.Chiral HPLC chromatograms of compounds <b>1</b> and <b>5</b> and NMR data of compounds <b>1</b>, <b>3</b>, <b>4</b>, and <b>5</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.oprd.0c00403/suppl_file/op0c00403_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, organic, applied
What problem does this paper attempt to address?